Efficacy and safety profile of 2nd line Anti TB drugs in DRTB patients in a tertiary care hospital of South Punjab

Hafiz Muhammad Rizwan, Moazzam Ali Atif, Mazhar Hussain, Rimsha Nazeer · 2024

Read Efficacy and safety profile of 2nd line Anti TB drugs in DRTB patients in a tertiary care hospital of South Punjab by Hafiz Muhammad Rizwan, Moazzam Ali Atif, Mazhar Hussain, Rimsha Nazeer (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11613365.txt.

Description

Hafiz Muhammad Rizwan, Moazzam Ali Atif, Mazhar Hussain, and Rimsha Nazeer weighed second-line drugs for drug-resistant tuberculosis in twenty twenty-four. Records came from a large hospital in South Punjab, Pakistan, covering patients treated from twenty eighteen to twenty twenty-one. The team tracked sputum test results, body weight, and side effects across the two-year course.

Positive sputum tests fell steadily over the twenty-four months, while clear tests rose from under ten percent at the start to twenty-eight percent by the end. Mean body weight climbed at each three-month check, from about forty-three point eight kilos to about fifty. Side effects were mostly mild to moderate, led by low mood, joint pain, and anxiety, with heart rhythm changes in about eleven percent. The authors say the regimens work, but call for close watch and care of side effects.

Catalog record

CREATORHafiz Muhammad Rizwan, Moazzam Ali Atif, Mazhar Hussain, Rimsha Nazeer
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11613365

Browse the full library · About the Tower of Babel